CN112679328A - Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone - Google Patents
Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone Download PDFInfo
- Publication number
- CN112679328A CN112679328A CN201910987122.7A CN201910987122A CN112679328A CN 112679328 A CN112679328 A CN 112679328A CN 201910987122 A CN201910987122 A CN 201910987122A CN 112679328 A CN112679328 A CN 112679328A
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- cyclohexen
- iodo
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009776 industrial production Methods 0.000 title abstract description 8
- 238000000034 method Methods 0.000 title description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000006192 iodination reaction Methods 0.000 claims abstract description 5
- 238000012805 post-processing Methods 0.000 claims abstract 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 29
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 19
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 14
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 10
- MAKRQTKPKWXSRR-UHFFFAOYSA-N 3-iodocyclohex-2-en-1-one Chemical compound IC1=CC(=O)CCC1 MAKRQTKPKWXSRR-UHFFFAOYSA-N 0.000 claims description 8
- 239000007810 chemical reaction solvent Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical group I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- PJVVPVVXUVHMOX-UHFFFAOYSA-N 3-(trifluoromethyl)cyclohex-2-en-1-one Chemical compound FC(F)(F)C1=CC(=O)CCC1 PJVVPVVXUVHMOX-UHFFFAOYSA-N 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 claims description 3
- 238000003682 fluorination reaction Methods 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- VZIQRQAPNKXHSB-UHFFFAOYSA-N ethyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound CCOC(=O)C(F)(F)S(F)(=O)=O VZIQRQAPNKXHSB-UHFFFAOYSA-N 0.000 claims description 2
- -1 fluorosulfonyl difluoroacetate methyl ester Chemical class 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- YMLAVJJQEPGJAP-UHFFFAOYSA-N 1-(bromomethyl)-2-phenylmethoxybenzene Chemical compound BrCC1=CC=CC=C1OCC1=CC=CC=C1 YMLAVJJQEPGJAP-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- PBWZKZYHONABLN-UHFFFAOYSA-M difluoroacetate Chemical compound [O-]C(=O)C(F)F PBWZKZYHONABLN-UHFFFAOYSA-M 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical group OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 5
- 230000026045 iodination Effects 0.000 abstract description 2
- 238000006692 trifluoromethylation reaction Methods 0.000 abstract description 2
- 238000011109 contamination Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000007039 two-step reaction Methods 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VPAYJEUHKVESSD-UHFFFAOYSA-N trifluoroiodomethane Chemical compound FC(F)(F)I VPAYJEUHKVESSD-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- XUHNTGWWKGZJNY-UHFFFAOYSA-N 2-(trifluoromethyl)cyclohex-2-en-1-one Chemical compound FC(F)(F)C=1C(CCCC1)=O XUHNTGWWKGZJNY-UHFFFAOYSA-N 0.000 description 1
- IPFSJCDRYRZTJU-UHFFFAOYSA-N 2-iodocyclohex-2-en-1-one Chemical compound IC1=CCCCC1=O IPFSJCDRYRZTJU-UHFFFAOYSA-N 0.000 description 1
- UGEJOEBBMPOJMT-UHFFFAOYSA-N 3-(trifluoromethyl)phenol Chemical compound OC1=CC=CC(C(F)(F)F)=C1 UGEJOEBBMPOJMT-UHFFFAOYSA-N 0.000 description 1
- BVSMYYHGYVHWCD-UHFFFAOYSA-N 3-bromocyclohex-2-en-1-one Chemical compound BrC1=CC(=O)CCC1 BVSMYYHGYVHWCD-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical class [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012025 fluorinating agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 231100000089 gene mutation induction Toxicity 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及一种3‑三氟甲基‑2‑环己烯‑1‑酮的工业化生产方法,以1,3‑环己二酮经碘代、三氟甲基化两步反应制得,收率相比于现有技术显著提高,且不需要高温高压等特殊反应条件,不涉及重金属污染试剂的使用,反应和后处理简单,产物易纯化,适合工业化生产。The invention relates to an industrialized production method of 3-trifluoromethyl-2-cyclohexene-1-ketone, which is prepared by using 1,3-cyclohexanedione through a two-step reaction of iodination and trifluoromethylation, Compared with the prior art, the yield is significantly improved, and special reaction conditions such as high temperature and high pressure are not required, the use of heavy metal contamination reagents is not involved, the reaction and post-processing are simple, the product is easy to purify, and it is suitable for industrial production.
Description
Technical Field
The invention relates to the field of synthesis of medical intermediates, in particular to an industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone.
Background
Fluorine atoms are often applied to the structural optimization of compounds due to strong electronegativity and small atomic radius, so that the physicochemical properties of the compounds, the drug effects, toxicity, metabolic processes and the like of drug molecules are improved, trifluoromethylated products occupy a large proportion in the fluorine atoms, and the introduction of trifluoromethyl can possibly improve the polarity, dipole moment, stability and lipophilicity of target products. 3-trifluoromethyl-2-cyclohexene-1-ketone as a medical intermediate can be used for preparing 3- (trifluoromethyl) cyclohexyl-1-alcohol, 3- (trifluoromethyl) phenol and the like so as to further synthesize various clinical candidate compounds or drug molecules.
There are two main methods for preparing 3-trifluoromethyl-2-cyclohexene-1-one reported in the prior literature.
Route 1(Journal of Fluorine Chemistry,101 (2); 199. sup. -; 202; 2000)
In the route 1, 2-cyclohexene-1-ketone is used as an initial raw material, and a target compound is obtained through trifluoromethylation and rearrangement. In the third step, the reaction conversion is incomplete, and the yield is only 28%; and pyridinium chlorochromate (PCC, containing heavy metal chromium) is used, chromium is a heavy metal with high toxicity, easily enters human cells, damages internal organs and DNA such as liver and kidney, accumulates in human body, has carcinogenicity, possibly induces gene mutation, and also causes serious pollution to the environment, so that the amplification use of the chromium is limited, and the chromium can only be used for synthesis at laboratory level.
Route 2(Tetrahedron Letters, (42), 4071-2; 1979)
Route 2 uses 3-bromo-2-cyclohexene-1-one as raw material, copper powder, hexamethylphosphoramide and trifluoroiodomethane are synthesized into CuCF3Then synthesizing a target compound with 3-bromo-2-cyclohexene-1-ketone; CuCF3The method is unstable, needs to be prepared at present, is gas trifluoroiodomethane, needs to be carried out under the conditions of sealing and high temperature of 120 ℃, has high requirements on reaction equipment, has certain safety risk, is not suitable for amplification operation, and has the yield of 40%.
Therefore, the development of an industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone with safety, environmental protection, low equipment requirement and good yield is still needed.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides the preparation method of the 3-trifluoromethyl-2-cyclohexene-1-ketone, which has the advantages of easily obtained raw materials of the reagent, safety, environmental protection, no need of special reaction conditions such as high temperature and high pressure, no use of heavy metal pollution reagents, simple reaction and post-treatment, easy purification of the product, higher yield than the route reported by the literature, and suitability for industrial production.
The preparation method of the 3-trifluoromethyl-2-cyclohexene-1-ketone comprises the following steps:
the method comprises the following steps: 1, 3-cyclohexanedione is used as a starting material,
preparing 3-iodine-2-cyclohexene-1-ketone by iodination;
step two: 3-iodine-2-cyclohexene-1-ketone reacts under the condition of a fluorination reagent to prepare 3-trifluoromethyl-2-cyclohexene-1-ketone, wherein the fluorination reagent is fluorosulfonyl difluoroacetic acid methyl ester, fluorosulfonyl difluoroacetic acid ethyl ester or trimethylsilyl 2- (fluorosulfonyl) difluoroacetic acid ester
Preferably, the reaction solvent in step one is toluene.
The inventor unexpectedly finds that in the solvent screening of the first step, compared with acetonitrile generally used in the reaction of the type in the prior art, toluene is used as a reaction solvent, so that the post-reaction treatment operation is simple, the operation of column chromatography can be avoided, the impurity content of the product in the first step can be remarkably reduced, and the method is more suitable for industrial production. Other materials such as dichloromethane and tetrahydrofuran have good solubility, but have low boiling points, so that the reaction is slow; n-heptane has poor solubility for raw materials, auxiliary materials and products; the temperature rise is very obvious in the process of feeding DMF as a solvent, and the temperature is not easy to control in the operation process.
Preferably, the reaction system of the iodination reaction in the step one is elementary iodine/triphenylphosphine/triethylamine or N-iodosuccinimide/triphenylphosphine/triethylamine.
Preferably, the reaction temperature in step one is 70-85 ℃.
Preferably, the fluorinating agent in the second step is methyl fluorosulfonyl difluoroacetate.
Preferably, the reaction solvent in the second step is N, N-dimethylformamide, and the catalyst is cuprous iodide or cupric iodide.
Preferably, the first step further comprises post-treatment, wherein the post-treatment is specifically quenching and washing after the reaction is finished, adding toluene for azeotropy after the solvent is dried by rotation, adding methyl tert-butyl ether into the residue, stirring and filtering, adding anhydrous magnesium chloride into the obtained filtrate for complexation, filtering again, and evaporating the obtained filtrate to dryness to obtain the 3-iodo-2-cyclohexen-1-one.
The preparation method provided by the invention has the advantages that the total yield of two steps is about 50%, compared with the prior art, the preparation method is obviously improved, special reaction conditions such as high temperature and high pressure are not required, the use of heavy metal pollution reagents is not involved, the reaction and post-treatment are simple, the product is easy to purify, and the preparation method is suitable for industrial production.
Detailed Description
EXAMPLE 13 preparation of iodo-2-cyclohexen-1-one
Toluene (16kg) was added to a double glass kettle (50L), triphenylphosphine (5.0kg,19.0mol,1.1eq.) was added with stirring, iodine solid (5.0kg,19.2mol,1.1eq.) was added in portions at 5-10 deg.C, stirring was carried out for 20min, and triethylamine (1.9kg,19.0mol,1.1eq.) was added. Then 1, 3-cyclohexanedione (1.8kg,16.5mol,1.0eq.) was added at 5-10 ℃ and after addition the temperature was slowly raised to 75-80 ℃ and maintained at this temperature for 16h of reaction.
And (3) post-treatment: adding saturated sodium bisulfite aqueous solution (10L) into the system after cooling, stirring for 10 minutes for liquid separation, removing solvent by organic phase under reduced pressure and azeotropically removing water by toluene (100kg), adding methyl tert-butyl ether (10L) after cooling to dryness, stirring for 1 hour, filtering, washing filter cake with methyl tert-butyl ether (5L), mixing filtrates, transferring into a kettle, adding anhydrous magnesium chloride (1.2kg), complexing for 2 hours, filtering, washing filter cake with methyl tert-butyl ether (10L), mixing filtrates, concentrating to dryness to obtain light yellow liquid (2.6kg), and purifying>98%。1HNMR(400MHz):6.81~6.82(s,1H),2.90~2.94(m,2H),2.42~2.45(m,2H),2.07~2.00)m,2H);GCMS:222.9。
EXAMPLE 23 preparation of trifluoromethyl-2-cyclohexen-1-one
Adding DMF (16kg) into a double-layer glass kettle (50L), and adding 3-iodo-2-cyclohexen-1-one (3.0kg,11.7mol,1.00eq.) and cuprous iodide (0.4kg, 2.3mol, 0.02eq.) with stirring; methyl fluorosulfonyl difluoroacetate (2.8kg,14.7mol,1.25eq.) was added in one portion, and the mixture was heated to 75-80 ℃ for reaction for 12 h. After the reaction is finished, the temperature is reduced to 20-25 ℃, methyl tert-butyl ether (10L multiplied by 3) is extracted for three times, and the organic phase is concentrated, desolventized and rectified to obtain 3-trifluoromethyl-2-cyclohexene-1-ketone (1.35kg) with the purity of 99%.1HNMR(400MHz):6.38-6.39(m,1H),2.49-2.52(m,4H),2.11-2.18(m,2H);
19FNMR(400MHz):71.15;GCMS:165.1。
EXAMPLE 3 preparation of 3-iodo-2-cyclohexen-1-one post-treatment screening
Referring to the preparation method of example 1, the reaction solvent was toluene or acetonitrile, and the post-treatment mode was selected, and the operation and results are shown in table 1.
TABLE 1
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910987122.7A CN112679328B (en) | 2019-10-17 | 2019-10-17 | Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910987122.7A CN112679328B (en) | 2019-10-17 | 2019-10-17 | Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112679328A true CN112679328A (en) | 2021-04-20 |
CN112679328B CN112679328B (en) | 2023-09-15 |
Family
ID=75444610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910987122.7A Active CN112679328B (en) | 2019-10-17 | 2019-10-17 | Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112679328B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201827406A (en) * | 2016-12-27 | 2018-08-01 | 美商百健Ma公司 | Nrf2 activator |
US20190047947A1 (en) * | 2017-08-14 | 2019-02-14 | Allergan, Inc. | 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof |
CN109438327A (en) * | 2018-12-28 | 2019-03-08 | 巢湖学院 | A kind of fused ring compound and preparation method thereof |
-
2019
- 2019-10-17 CN CN201910987122.7A patent/CN112679328B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201827406A (en) * | 2016-12-27 | 2018-08-01 | 美商百健Ma公司 | Nrf2 activator |
US20190047947A1 (en) * | 2017-08-14 | 2019-02-14 | Allergan, Inc. | 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof |
CN109438327A (en) * | 2018-12-28 | 2019-03-08 | 巢湖学院 | A kind of fused ring compound and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
FAIYAZ KHAN 等: "Palladium-Catalyzed Ullmann Cross-Coupling of β-Iodoenones and β-Iodoacrylates with o-Halonitroarenes or o-Iodobenzonitriles and Reductive Cyclization of the Resulting Products To Give Diverse Heterocyclic Systems" * |
YOSHIRO KOBAYASHI 等: "TRIFLUOROMETHYLATION OF ALIPHATIC HALIDES WITH TRIFLUOROMETHYL COPPER" * |
Also Published As
Publication number | Publication date |
---|---|
CN112679328B (en) | 2023-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020147861A1 (en) | Electrochemical preparation method for β-trifluoromethylamide compound | |
US11820724B2 (en) | Method for preparing 2-ethyl-4-fluoro-1-nitrobenzene | |
JP2018523662A (en) | Novel process for producing chromanone derivatives | |
JP7144873B2 (en) | Method for producing sugammadex sodium salt | |
JP2002193887A (en) | Method for producing iodonium salt compound | |
JPH10505084A (en) | Method for producing tetrabromobisphenol-A by reducing formation of methyl bromide | |
CN107540655B (en) | Novel method for preparing S- (perfluoroalkyl) -dibenzothiophene trifluoromethanesulfonate | |
CN112679328A (en) | Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone | |
JP3480825B2 (en) | Purification method of 1,1,1,5,5,5-hexafluoroacetylacetone | |
CN117304094A (en) | Synthesis method of 3-trifluoromethyl pyridine or 3-difluoro methyl pyridine compound | |
CN110698352A (en) | A kind of synthetic method of 3-bromo-5-aminocatechol dimethyl ether | |
CN111574384B (en) | Preparation method of chiral 1-amino-2-propanol | |
KR101894091B1 (en) | New method for preparation of chromanone derivatives | |
JP3806962B2 (en) | Method for producing 3,5-bis (trifluoromethyl) bromobenzene | |
CN113582847B (en) | Improved method for preparing iodo-benzoic acid (ester) by sandmeyer reaction | |
CN113461615A (en) | Preparation method of 4-fluoro-1H-pyrazole | |
JP2004131399A (en) | Method for producing cis-hexahydroisoindoline | |
CN109400507A (en) | The synthesis of Ailamode intermediate impurities | |
CN109081826B (en) | Preparation method of oxidant IBX | |
CN116813508A (en) | Method for synthesizing 5-halogeno-2-methylbenzoic acid with high selectivity | |
JP2008174552A (en) | Method for producing 4-perfluoroisopropylanilines | |
CN107434758A (en) | Method for synthesizing monobromo condensed ring aromatic hydrocarbon compound | |
JPH10265449A (en) | Production of substituted benzonitrile | |
JPS6232188B2 (en) | ||
JP3924027B2 (en) | Sodium orthohydroxymandelate / phenol / water complex, process for its preparation and use for the separation of sodium orthohydroxymandelate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |